Clinical Study
Infliximab Extends the Duration until the First Surgery in Patients with Crohn’s Disease
Table 4
Factors associated with the nonoperative rate until the first surgery (multivariate analysis).
| | | Hazard ratio | 95% CI |
| Sex | Female | 0.605 | 0.339–1.081 | Type of disease | Colitis | 0.086 | 0.011–0.657 | Corticosteroid | (+) | 0.912 | 0.519–1.604 | Immunomodulator | (+) | 1.057 | 0.569–1.966 | Infliximab | (+) | 0.256 | 0.122–0.540 |
|
|